Principle Wealth Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Principle Wealth Partners's NVS Position: Q3 2026 in Review
Principle Wealth Partners increased its Novartis (NVS) stake by 1.8% in Q3 2026, buying an estimated $13.3K and bringing the position to 4,860 shares worth $693K. The position accounts for 0.03% of the portfolio, ranked #220.
Principle Wealth Partners first reported a position in NVS in Q2 2020 and has held it in 25 quarters since. The position peaked at $748K in Q2 2026. 1,212 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Principle Wealth Partners held 4,860 shares of Novartis worth $693K as of Q3 2026.
- Principle Wealth Partners bought 88 Novartis shares in Q3 2026, an estimated $13.3K.
- Novartis made up 0.03% of Principle Wealth Partners's portfolio in Q3 2026, its #220 holding.
- Principle Wealth Partners first reported a position in Novartis in Q2 2020 and has held it in 25 quarters since.
- Principle Wealth Partners's Novartis position peaked at $748K in Q2 2026.
- 1,212 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Principle Wealth Partners's 13F filing for Q3 2026, filed 2 Nov 2026.